SCHEMBL30036996

SCHEMBL30036996

Cc1ccc(-c2nc(Cl)ncc2Cl)cc1F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNQ3 O43525 2/20 0.42
▸ KCNQ2 O43526 2/20 0.42
▸ KCNE1 P15382 2/20 0.42
▸ KCNQ1 P51787 2/20 0.42
▸ KCNQ5 Q9NR82 1/20 0.42
▸ BTK Q06187 1/20 0.40
▸ KMO O15229 2/20 0.40
▸ NISCH Q9Y2I1 1/20 0.38
▸ CHRNA7 P36544 1/20 0.37
▸ PTGS2 P35354 1/20 0.36
▸ PDK1 Q15118 1/20 0.36
▸ PDK2 Q15119 1/20 0.36
▸ PDK3 Q15120 1/20 0.36
▸ PDK4 Q16654 1/20 0.36
▸ GRIN2B Q13224 1/20 0.36
▸ RPS6KA5 O75582 1/20 0.34
▸ ABL1 P00519 1/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ MAPK1 P28482 2/20 0.34
▸ CTSA P10619 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25551797 1.00 KCNQ3 (0.42) KCNQ3KCNQ2KCNE1KCNQ1KCNQ5
SCHEMBL30036275 0.88 KMO (0.40) KCNQ3KCNQ2KCNE1KCNQ1KCNQ5
SCHEMBL25551800 0.88 KMO (0.40) KCNQ3KCNQ2KCNE1KCNQ1KCNQ5
SCHEMBL25551795 0.83 KMO (0.59) KCNQ3KCNQ2KCNE1KCNQ1KCNQ5
SCHEMBL30035839 0.83 KMO (0.59) KCNQ3KCNQ2KCNE1KCNQ1KCNQ5
SCHEMBL12813119 0.78 AXL (0.49) KMONISCHCHRNA7PDK1PDK2
SCHEMBL30919676 0.78 BTK (0.43) BTKPDK1PDK2PDK4RPS6KA5
SCHEMBL31281284 0.78 CYP11B2 (0.53) —
SCHEMBL29340337 0.78 BTK (0.43) BTKKMOPDK1PDK2PDK3
SCHEMBL27263191 0.78 BTK (0.43) BTKPDK1PDK2PDK4RPS6KA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115515940-A Inhibitors of receptor interacting protein kinase I for the treatment of disease 德州大学系统董事会 2022-12-23 — — CN disclosed
Send feedback